1. What do you think are the possible major tensions that exist when a pharmaceutical firm forms an alliance with a biotechnology firm?
2. How would you try to address those tensions?
3. Identify different challenges that exist for maintaining or strengthening an ongoing alliance versus beginning a new relationship.